Activation of suppressor T cells by tumour cells and specific antibody

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Nature

• Publication date

  1974-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/250594a0PMID 4546445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.

  1973cited by this paper
• THYMUS-DERIVED LYMPHOCYTES PRODUCE AN IMMUNOLOGICALLY SPECIFIC MACROPHAGEARMING FACTOR

  1972cited by this paper
• Central inhibition of cellular immunity to leukemia L1210 by isoantibody.

  1972cited by this paper
• Suppressor T cells.

  1972cited by this paper
• Specific inhibition of receptors for cytophilic antibody on macrophages by isoantibody.

  1972cited by this paper
• The regulatory influence of activated T cells on B cell responses to antigen.

  1972cited by this paper
• Neonatally Induced Allograft Tolerance may be mediated by Serum-borne Factors

  1971cited by this paper
• Serum-mediated Immunological Non-reactivity between Histoincompatible Cells in Tetraparental Mice

  1971cited by this paper
• Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

  1971cited by this paper
• Infectious immunological tolerance.

  1971cited by this paper
• Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

  1971cited by this paper
• Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

  1970cited by this paper
• Immunological enhancement as studied by cell culture techniques.

  1970cited by this paper
• Extrinsic Cotton effect and immunological properties of the p-azobenzenearsonate hapten attached to a helical amino acid copolymer.

  1970cited by this paper
• Regulatory effect of antibody on the immune response.

  1968cited by this paper
• Acceptance of Tumor Homografts by Mice Injected with Antiserum. I. Activity of Serum Fractions.∗ †

  1956cited by this paper
• The effect of prior injections of tissue antiserums on the survival of cancer homoiografts in mice.

  1952cited by this paper

• Highlights of 2024: Tregs immunometabolism and how to counter inflammatory niches

  2025cites this paper
• Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential

  2025cites this paper
• Multifactorial Risk Prediction Analysis of Liver Metastasis in Colorectal Cancer: Incorporating PD-L1 CPS and Other Factors.

  2024cites this paper
• Regulatory T cell dysfunction and its implication for cell therapy.

  2023cites this paper
• The role of the immunoescape in colorectal cancer liver metastasis

  2021cites this paper
• Effectiveness of Perioperative Immunologic Markers Monitoring for Predicting Early Acute Cellular Rejection After Living Donor Liver Transplantation.

  2019cites this paper
• Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells.

  2017cites this paper
• Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells

  2016cites this paper
• Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.

  2012cites this paper
• Abnormal variation of the immune response as related to cancer

  2008cites this paper
• Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients

  2008cites this paper
• International progress in cancer gene therapy

  2008cites this paper
• Regulatory CD4 T cells: sensing the environment.

  2008cites this paper
• Leptin and autoimmunity: a key role of leptin in thecontrol of regulatory T cell proliferation

  2008cites this paper
• Discovery and development of therapeutic cancer vaccines.

  2007cites this paper
• International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China

  2007cites this paper
• Vaccines to treat cancer‐an old approach whose time has arrived

  2007cites this paper
• T Cells and Dendritic Cells in Immuno-Mediated Skin Pathology

  2006cites this paper
• Membrane alterations in health and disease with particular reference to immune function and cancer

  2004cites this paper
• Antitumor activity with nontoxic doses of protein A

  2004cites this paper
• An integrated model of immunoregulation mediated by regulatory T cell subsets.

  2004cites this paper
• Novel approaches to therapeutic cancer vaccines

  2003cites this paper
• Therapeutic vaccination with tumor cells that engage CD137

  2003cites this paper
• Systemic lupus erythematosus and B-cell hematologic neoplasm

  2001cites this paper
• Correlation of level of gangliosides in plasma with cancer in human patients.

  2000cites this paper
• The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1.

  2000cites this paper
• Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.

  1996cites this paper
• Immunodominant deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro

  1996cites this paper
• New concepts in immunobiology

  1995cites this paper
• Mechanisms of transplantation tolerance.

  1994cites this paper
• Tumor infiltrating lymphocytes.

  1993cites this paper
• Successful therapy to a progressive tumor using monoclonal-antibodies to T-cell regulatory molecules and interleukin-2.

  1993cites this paper
• T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.

  1992cites this paper
• Depression of cell‐mediated immunity in plasmacytoma‐bearing mice

  1991cites this paper
• Suppression of Lymphokine-Activated Killer Cell Cytotoxicity by a Soluble Factor Produced by Squamous Tumors of the Head and Neck

  1990cites this paper
• Changes of immunological patterns of human cancer cells treated in vitro with a triazene compound.

  1989cites this paper
• Abnormal Variation of the Immune System as Related to Cancer

  1989cites this paper
• Cellular Mechanisms in Neonatal and Adult Tolerance

  1989cites this paper
• Successful immunotherapy to malignant cells with monoclonal antibody to suppressor T cells

  1988cites this paper
• Host-tumor interactions in immunosurveillance against cancer.

  1988cites this paper
• Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.

  1988cites this paper
• Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis

  1987cites this paper
• Defective T-lymphocyte chemotactic factor production in patients with established malignancy.

  1986cites this paper
• Suppressor Cells and Malignancy

  1986cites this paper
• Suppression of in vivo tumor formation induced by simian virus 40- transformed cells in mice receiving antiidiotypic antibodies

  1985cites this paper
• Immune Complexes in Human and Experimental Disease

  1985cites this paper
• Blocking (suppressor) factors, immune complexes, and extracorporeal immunoadsorption in tumor immunity.

  1985cites this paper
• Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A.

  1985cites this paper
• Activation of suppressor T cells by low-molecular-weight factors secreted by spleen cells from tumor-bearing mice.

  1985cites this paper
• Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies.

  1984cites this paper
• Immunotherapy in genitourinary neoplasia.

  1984cites this paper
• Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses.

  1984cites this paper
• Suppressor T cells and the immune response to tumors.

  1984cites this paper
• Effect of frequency of plasma adsorption over protein A-containing Staphylococcus aureus on regression of rat mammary adenocarcinomas: modification of antitumor immune response and tumor histopathology.

  1984cites this paper
• [Immune evaluation in oncologic surgery].

  1984cites this paper
• Suppressor factors in tumor immunity.

  1984cites this paper
• Idiotype network interactions in tumor immunity.

  1984cites this paper
• Antigen-specific suppressor ("blocking") factors in tumor immunity.

  1983cites this paper
• Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.

  1983cites this paper
• Suppressor mechanisms in tumor immunity

  1983cites this paper
• Circulating immune complexes in rats with metastasizing or nonmetastasizing mammary tumor.

  1983cites this paper
• [Influence of the localization on the prognostic value of E, E-active and autologous rosettes in lung, esophagus and otorhinolaryngologic cancer].

  1983cites this paper
• CHAPTER 3 – Immunological Tolerance

  1982cites this paper
• Escape of Tumours from Immunological Destruction

  1982cites this paper
• Drug-mediated changes of tumour cell immunogenicity and antigenicity.

  1982cites this paper
• Mechanism of regression of mammary adenocarcinomas in rats following plasma adsorption over protein A-containing Staphylococcus aureus.

  1982cites this paper
• Tumour-induced changes in murine lymphocyte profiles.

  1982cites this paper
• The role of Ia antigens and Fc receptor-bearing T-cells in the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.

  1982cites this paper
• Suppressor Cells in Tumor-Host Interactions

  1982cites this paper
• Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.

  1982cites this paper
• Immunogenicity of Lewis Lung Carcinoma in C57BL/6 Mice. I. Tumor-Associated Antigen(S) in Peripheral Blood, Thymus and Spleen of Tumor-Bearing Mice

  1982cites this paper
• Suppressor cells assayed by numerical and functional tests in chronic renal failure.

  1982cites this paper
• Cell‐mediated suppression of tumor immunity has a non‐specific component. I. Evidence from transplantation tests

  1981cites this paper
• Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.

  1981cites this paper
• Generation of suppressor cells by aggregated human globulin.

  1981cites this paper
• Immunological aspects of intrinsic glial tumors.

  1981cites this paper
• INFLUENCE OF GENOTYPE, PROTEIN-CALORIE RESTRICTION AND THEIR INTERACTION UPON RSV-INDUCED TUMORS IN CHICKENS

  1980cites this paper
• Radiosensitive, thymic hormone-sensitive peripheral blood suppressor cell activity in cancer patients.

  1980cites this paper
• Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells.

  1980cites this paper
• Inhibition of the immune response by Fc receptor-bound specific antibody on T lymphocytes.

  1980cites this paper
• Suppressive and cytostatic activities in the spleen of tumor-bearing hamsters.

  1980cites this paper
• Inhibition of mitogen-induced lymphokine production by Cyclosporin A

  1980cites this paper
• Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.

  1980cites this paper
• Basic strategies of the immune system in the regulation of antibody response

  1980cites this paper
• Prognosis in lymphoblastic leukaemia related to plasma mediated inhibition of incorporation of tritiated thymidine by transformed lymphocytes.

  1980cites this paper
• Surface proteins on Cloudman melanoma cells.

  1980cites this paper
• Immunotherapy and genitourinary neoplasia.

  1980cites this paper
• Suppressor cells in immunodepressed bladder and prostate cancer patients.

  1980cites this paper
• Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease

  1980cites this paper
• T-T hybridoma product specifically suppresses tumor immunity.

  1980cites this paper
• Neutralization of immune complex inhibition of antibody dependent cellular cytotoxicity in vitro by Staphylococcus-aureus protein A.

  1979cites this paper
• Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia

  1979cites this paper
• "The immunological orchestra in cancer".

  1979cites this paper
• Suppressor cells: permitters and promoters of malignancy?

  1979cites this paper
• Reversal of macrophage-augmented MLR reactivity by tumor-induced splenic suppressor T cells and their soluble factor(s).

  1979cites this paper
• Augmentation of antitumor cytotoxicity of MOPC-315 tumor bearer spleen cells by depletion of dinitrophenol-adherent cells prior to in vitro immunization.

  1979cites this paper
• Modulation of immunity by bacillus Calmette-Guérin (BCG).

  1979cites this paper
• Antitumor effect of whole-body X-irradiation: possible role of an X-ray-sensitive T suppressor cell population.

  1979cites this paper
• Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice.

  1979cites this paper
• Suppressor T cells induced by soluble immune complexes can adoptively transfer inhibition of cytophilic antibody receptors on macrophages.

  1979cites this paper